Anti-αvβ3 Integrin Therapeutic Antibody (Etaracizumab/Etaratuzumab/Medi-522)
Recombinant humanized (from mouse) antibody expressed in CHO binding to human αVβ3 integrin. Etaracizumab is a humanized monoclonal antibody which is being investigated for the treatment of metastatic melanoma, prostate cancer, ovarian cancer and various other types of cancer.
| Supplier | Creative Biolabs |
|---|---|
| Product # | TAB-705 |
| Pricing | Inquiry |
| Host | Mouse |
| Target | αVβ3 integrin |
| Species Reactivity | Human |
| Type | IgG2 - kappa |
| Applications | FC, IP, ELISA, Neut, FuncS, IF, IHC |
| Storage | Store it under sterile conditions at -20°C upon receiving. Recommend to pack the protein into smaller quantities for optimal storage. |